MIMO Biosciences

MIMO Biosciences is a pioneering spin-off advancing preclinical research in hematological diseases. Our mission is to accelerate the development of innovative therapies by providing exclusive, disease-relevant animal models that closely mimic human pathology. Our value lies in scientific excellence. MIMO was born from the Hematology and Hemato-Oncology Lab of Dr. José Ángel Martínez-Climent at the University of Navarra and CIMA, a world-class research group with a strong track record in translational oncology. Our scientists bring deep expertise in hematology, cancer biology, and immunotherapy, supported by high-impact publications in top journals such as Nature, Nature Medicine, Blood, and Blood Cancer Discovery. We add value in: * Preclinical testing of novel immuno-oncologic therapies * Proprietary animal models that replicate human hematologic cancers * Study design, execution, and expert data interpretation * Scientific credibility and close collaboration with academia and industry We provide our partners with predictive, translatable platforms that reduce risk and increase the success of early-stage drug development. Based in Pamplona, Spain | Working globally Let’s bring better therapies to patients—faster. Interested in collaborating with us? Let’s talk.